Prevalence of concomitant medications in older HIV+ patients and comparison with general population

References

• Hasse B, Ledergerber B, Furrer H, Battegay M, Hirschel B, Cavassini M, et al. Morbidity and aging in HIV-infected persons: the swiss HIV cohort study. Clin Infect Dis. 2011;53:1130–1139.
   PubMed Web of Science ®Google Scholar
• Blanco JR, Jarrín I, Vallejo M, Berenguer J, Solera C, Rubio R, et al. Definition of advance age in HIV infection: looking for an age cut-off. AIDS Res Hum Retroviruses. 2012;28:1000–1006.
   PubMed Web of Science ®Google Scholar
• Work Group for the HIV and Aging Consensus Project. Summary report from the human immunodeficiency virus and aging consensus project: treatment strategies for clinicians managing older individuals with the human immunodeficiency virus. J Am Geriatr Soc. 2012;60:974–979.
   PubMed Web of Science ®Google Scholar
• Guaraldi G, Orlando G, Zona S, Menozzi M, Carli F, Garlassi E, et al. Premature age-related comorbidities among HIV-infected persons compared with the general population. Clin Infect Dis. 2011;53:1120–1126.
   PubMed Web of Science ®Google Scholar
• Justice AC. HIV and aging: time for new paradigm. Curr HIV/AIDS Rep. 2010;7:69–76.
   PubMedGoogle Scholar
• Gleason LJ, Luque AE, Shah K. Polypharmacy in the HIV-infected older adult population. Clin Interv Aging. 2013;8:749–763.
   PubMed Web of Science ®Google Scholar
• Edelman EJ, Gordon KS, Glover J, McNicholl IR, Fiellin DA, Justice AC. The next therapeutic challenge in HIV: polypharmacy. Drugs Aging. 2013;30:613–628.
   PubMed Web of Science ®Google Scholar
• Marzolini C, Elzi L, Gibbons S, Weber R, Fux C, Furrer H, et al. Prevalence of comedications and effect of potential drug-drug interactions in the Swiss HIV Cohort Study. Antivir Ther. 2010;15:413–423.
   PubMed Web of Science ®Google Scholar
• Marzolini C, Back D, Weber R, Furrer H, Cavassini M, Calmy A, et al. Ageing with HIV: medication use and risk for potencial drug-drug interactions. J Antimicrob Chemother. 2011;66:2107–2111.
   PubMed Web of Science ®Google Scholar
• Holtzman C, Armon C, Tedaldi E, Chmiel JS, Buchacz K, Wood K, et al. Polypharmacy and risk of antiretroviral drug interactions among the aging HIV-infected population. J Gen Intern Med. 2013;10:1302–1310.
   Web of Science ®Google Scholar
• Tseng A, Szadkowski L, Walmsley S, Salit I, Raboud J. Association of age with polypharmacy and risk of drug interactions with antiretroviral medications in HIV-positive patients. Ann Pharmacother. 2013;47:1429–1439.
   PubMed Web of Science ®Google Scholar
• WHOCC. WHO Collaborating Centre for Drug Statistics Methodology, ATC classification index with DDDs. Oslo www.whocc.no/atc_ddd_index/. Accessed June, 2012 2012.
   Google Scholar
• Gnjidic D, Hilmer SN, Blyth FM, Naganathan V, Waite L, Seibel MJ, et al. Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes. J Clin Epidemiol. 2012;65:989–995.
   PubMed Web of Science ®Google Scholar
• Richardson K, Ananou A, Lafortune L, Brayne C, Matthews FE. Variation over time in the association between polypharmacy and mortality in the older population. Drugs Aging. 2011;28:547–560.
   PubMed Web of Science ®Google Scholar
• Marcum ZA, Amuan ME, Hanlon JT, Aspinall SL, Handler SM, Ruby CM, et al. Prevalence of unplanned hospitalizations caused by adverse drug reactions among older veterans. J Am Geriatr Soc. 2012;60:34–41.
   PubMed Web of Science ®Google Scholar
• Malo-Fumanal S, Rabanaque-Fernández MJ, Feja-Solana C, Lallana-Alvarez MJ, Armesto-Gómez J, Bjerrum L. [Differences in outpatient antibiotic use between a Spanish region and Nordic country]. Enferm Infecc Microbiol Clin. 2014;32:412–417.
   PubMed Web of Science ®Google Scholar
• Aguilar-Palacio I, Carrera-Lasfuentes P, Poblador-Plou B, Prados-Torres A, Rabanaque-Hernández MJ. [Morbidity and drug consumption. Comparison of results between the National Health Survey and electronic medical records]. Gac Sanit. 2014;28:41–47.
   PubMed Web of Science ®Google Scholar
• Shah SS, McGowan JP, Smith C, Blum S, Klein RS. Comorbid conditions, treatment, and health maintenance in older persons with human immunodeficiency virus infection in New York City. Clin Infect Dis. 2002;35:1238–1243.
   PubMed Web of Science ®Google Scholar
• Goulet JL, Fultz SL, Rimland D, Butt A, Gibert C, Rodriguez-Barradas M, et al. Do patterns of comorbidity vary by HIV status, age, and HIV severity? Clin Infect Dis. 2007;15:1593–1601.
   Web of Science ®Google Scholar
• Onen NF, Overton ET, Seyfried W, Stumm ER, Snell M, Mondy K, et al. Aging and HIV infection: a comparison between older HIV-infected persons and the general population. HIV Clin Trials. 2010;11:100–109.
   PubMed Web of Science ®Google Scholar
• Blanco JR, Caro AM, Pérez-Cachafeiro S, Gutiérrez F, Iribarren JA, González-García J, et al. HIV infection and aging. AIDS Rev. 2010;12:218–230.
   PubMed Web of Science ®Google Scholar
• Justice AC, McGinnis KA, Atkinson JH, Heaton RK, Young C, Sadek J, et al. Psychiatric and neurocognitive disorders among HIV-positive and negative veterans in care: Veterans Aging Cohort Five-Site Study. AIDS. 2004;1:S49–S59.
   Google Scholar
• Schmiemann G, Bahr M, Gurjanov A, Hummers-Pradier E. Differences between patient medication records held by general practitioners and the drugs actually consumed by the patients. Int J Clin Pharmacol Ther. 2012;50:614–617.
   PubMed Web of Science ®Google Scholar
• Furler MD, Einarson TR, Walmsley S, Millson M, Bendayan R. Polypharmacy in HIV: impact of data source and gender on reported drug utilization. AIDS Patient Care STDS. 2004;18:568–586.
   PubMed Web of Science ®Google Scholar